| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |